How can gene-editing of human pluripotent stem cells help cystic fibrosis?
S. Cuevas Ocana (Newcastle upon Tyne, United Kingdom), A. Wong (Toronto, Canada), M. Aushev (Newcastle upon Tyne, United Kingdom), J. Yang (Toronto, Canada), N. Perkins (Newcastle upon Tyne, United Kingdom), C. Bear (Toronto, Canada), J. Rossant (Toronto, Canada), M. Gray (Newcastle upon Tyne, United Kingdom)
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Session: Advances in care and monitoring of cystic fibrosis
Session type: Oral Presentation
Number: 2125
Disease area: Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Cuevas Ocana (Newcastle upon Tyne, United Kingdom), A. Wong (Toronto, Canada), M. Aushev (Newcastle upon Tyne, United Kingdom), J. Yang (Toronto, Canada), N. Perkins (Newcastle upon Tyne, United Kingdom), C. Bear (Toronto, Canada), J. Rossant (Toronto, Canada), M. Gray (Newcastle upon Tyne, United Kingdom). How can gene-editing of human pluripotent stem cells help cystic fibrosis?. 2125
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: